 Home > Medical News >

Medical Research Articles

Kangpu Bio successfully completes Phase I clinical study of KPG-818 in healthy subjects in the United States

 Time of Update: 2020-06-08

emerson electric company morphine half life zofran 8 mg company safety schrodinger company

Recently, Kangpu Bio Pharmaceutical (http:// Technology (Shanghai) Limited Company (http:// ("Kangpu Biopharmaceuticals") announced that the company has successfully completed its Class I crea
EMA accepts Astellas Xtandi for treatment of metastatic hormone-sensitive prostate cancer patients

 Time of Update: 2020-06-08

data logger thermometer pfizer application clorox safety data sheet risk level cell signaling

recently, Japanese drugmaker Astellas announced that the European Medicines (http:// Authority (EMA) has accepted a Class II change application for the anti-cancer drug Xtandi (enzalutamide, nzar
U.S. FDA Grants Magenta Company MGTA-456 Advanced Therapy For Multiple Genetic Metabolic Disorders

 Time of Update: 2020-06-08

months white blood cells high cancer cell stop oligopotent stem cells fda food registration

The U.S Food and Drug (http:// Administration ( FDA (http:// ) has granted the one-time cell therapy MGTA-456 advanced therapeutic (RMAT) for the treatment of multiple inherited metabolic disord
European Commission approves Lonsurf for treatment of adult patients with metastatic stomach cancer

 Time of Update: 2020-06-08

photodynamic therapy 5 1 2 inches gastric fluid 1 2 dichlorobutane drug therapy definition

recently, French drugmaker Sviar and partner Dapeng Pharmaceutical (http:// announced that the European Commission (EC) has approved Lonsurf (trifluridine/tipiracil) for the treatment of adult pa
FDA grants list of orphans for pancreatic cancer at listal Genomics CG-745

 Time of Update: 2020-06-08

advanced clinical products bone marrow deficiency petrified bone marrow infectious diseases caused bone marrow

The U.S Food and Medicines (http:// Administration (http:// http:// has granted CG-745 orphan drug treatment for pancreatic cancer to the cg-745, the (http:// announced. CG-745 is a clinic
First three launched oral FLT3 inhibitor Vanflyta (quizartinib) in Japan

 Time of Update: 2020-06-08

drug field test 21 7 simplified british pharmaceutical companies 65105n drug test 3 4 water

recently, the Japanese pharmaceutical company First Pharmaceutical (http:// announced the launch of oral FLT3 inhibitor Vanflyta (quizartinib) in Japan for the treatment of recurrent/incurable FL
Keystone Pharmaceuticals BLU-667 completes first Chinese patient administration in Phase I registered trial

 Time of Update: 2020-06-08

glp 1 drugs type 3 anodize phenazopyridine 100 mg provigil 100 mg zovia 1 35

Recently, Cornerstone Pharmaceuticals (Suzhou) Limited Company (http:// announced that its BLU-667 completed its first Chinese patient administration in the Phase I Registered Trial (http://
Xi'an Yangsen Ansen ® (Apatamine tablets) received accelerated approval from the State Drug Administration

 Time of Update: 2020-06-08

new drug pink non profit orginizations acid drug new alzheimer's drug 2016 drug interaction search

Recently, Johnson and Johnson Corporation (http:// in China Pharmaceutical (http:// subsidiary Xi'an Yangsen Pharmaceutical Co., Ltd announced that its Ansen ® (Apatama tablets) has been appro
FDA approves Mercado PD-1 inhibitor Keytruda for treatment of patients with esophageal squamous cell carcinoma

 Time of Update: 2020-06-08

2 5 hexanedione localized cancer pd 1 signaling system 1 cd 1 2

today, the u.S FDA (http:// approved the company's heavy-duty PD-1 inhibitor Keytruda as a single-drug therapy for patients with recurrent late-stage or metastatic esophageal squamous cell carcin
Sansheng Pharmaceutical pre-charged Isep ® the production of new drugs for water needles received by the State Drug Administration

 Time of Update: 2020-06-08

drug baggies identification colony life insurance mechanism drug action minneapolis water company cheat drug test

Yesterday (July 29), China's leading bio pharmaceutical (http:// company (http:// Sansheng Pharmaceuticals (01530 HK) announced that the antibody fusion protein drug (http:// product (http:
Cinda Bio and Lilly Pharmaceuticals develop an innovative gastric acid regulator (OXM3)

 Time of Update: 2020-06-08

long lyrica work advanced health solutions parkinson's treatment drug colitis natural treatment 87 blood sugar

Recently, Cinda Bio announced a strategic partnership with Lilly Pharmaceutical (http:// to jointly promote the development and commercialization of an innovative gastric acid regulatory compound
FDA grants Aeglea's confirmation of the drug pegzilarginase breakthrough therapy

 Time of Update: 2020-06-08

equate fiber therapy adalimumab therapy director research development biotherapeutics vertex physical therapy

ARG1-D, also known as arginineemia, is a rare genetic disorder Patients due to mutations in the ARG1 gene, resulting in the lack of argininase 1 in the liver, arginine metabolism disorders Aeglea B
FDA grants fast-track eligibility for FX-322 fast-track, a research candidate drug for hearing recovery

 Time of Update: 2020-06-08

list healthy meals steel compound mixture hep 2 cells iodine function body main ingredient sudafed

Today, FrequencY Therapeutics Biotechnology (http:// announced that its research candidate drug (http:// FX-322 has been granted fast-track eligibility by the FDA (http:// The drug also ach
Adelyx's key Phase 3 trial for the treatment of hyperphosphateemia reaches primary and all secondary endpoints

 Time of Update: 2020-06-08

leflunomide 10 mg sodium chloride safety foxy drug pravastatina 10 mg dex drug

recently, Ardelyx company (http:// announced that it had reached its primary and all secondary endpoint scored in the critical phase 3 trial (http:// for the treatment of hyperphosphateemia in
FDA accepts new drug applications for VX-445 (elexacaftor), tezacaftor and ivacaftor combination therapies

 Time of Update: 2020-06-08

ert clinical average cholesterol level positive control biology level paragon gene therapy

recently, Vertex Pharmaceuticals (http:// announced that the U.S FDA (http:// accept the new drug (http:// http:// application (NDA) for the combination of vX-445, tezacaftandandandandanda
Incyte conducts its first patient treatment in a phase III clinical trial of ruxolitinib cream treatment

 Time of Update: 2020-06-08

1 3 dimethylamylamine 2 3 dimethylheptane global clinical trials 1 cot 2 parkinson's treatment drug

Recently, Incyte (http:// announced that the first patient has been treated in the Phase III TRuE-V Clinical Trial (http:// project to evaluate the treatment of vitiligo in the ruxolitinib cre
AstraZeneca announces results of Phase 3 clinical trial sedaton and aspirin combination

 Time of Update: 2020-06-08

vaccines fda approved people single world blood agglutination test adp 2 0 diagnose heart attack

recently (September 3) AstraZeneca (http:// published detailed results of phase 3 clinical trial (http:// THEMIS results showed that a combination of ticagrelor and aspirin combined with aspi
Twenty scientific research institutions gather edgy at The 2019 Shanghai Biofermentation Exhibition

 Time of Update: 2020-06-08

technical sheet environmental problems osmosis products industrial waste disposal molecular technology

, this exhibition will gather 2000 biofermentation research institutions to participate in the industry to bring the latest research results, production processes, technical problems to answer, for the biofermentation industry escort!
FDA accepts biologics license application for Mercado-Ontom Ebola vaccine V920

 Time of Update: 2020-06-08

health continuum definition fda approved products united states food 3 4w 1 vitamin liver health

Today, http:// the http:// of the U.S FDA (http:// ) has accepted an application for a biologic license (BLA ) for its Ebola vaccine to prevent disease caused by the Ebola virus, the http:// htt
Clinuvel's Scenese (afamelanotide) is approved for listing by FDA

 Time of Update: 2020-06-08

eaa amino acids alpha musk alpha virus total human epoetin alpha

recently, the u.S FDA (http:// announced the approval of Clinuvel (http:// development of Scenesse (http:// to treat adult patients with skin damage caused by red blood cell-generating protosi

Go to Page

Medical Research Articles

Kangpu Bio successfully completes Phase I clinical study of KPG-818 in healthy subjects in the United States

EMA accepts Astellas Xtandi for treatment of metastatic hormone-sensitive prostate cancer patients

U.S. FDA Grants Magenta Company MGTA-456 Advanced Therapy For Multiple Genetic Metabolic Disorders

European Commission approves Lonsurf for treatment of adult patients with metastatic stomach cancer

FDA grants list of orphans for pancreatic cancer at listal Genomics CG-745

First three launched oral FLT3 inhibitor Vanflyta (quizartinib) in Japan

Keystone Pharmaceuticals BLU-667 completes first Chinese patient administration in Phase I registered trial

Xi'an Yangsen Ansen ® (Apatamine tablets) received accelerated approval from the State Drug Administration

FDA approves Mercado PD-1 inhibitor Keytruda for treatment of patients with esophageal squamous cell carcinoma

Sansheng Pharmaceutical pre-charged Isep ® the production of new drugs for water needles received by the State Drug Administration

Cinda Bio and Lilly Pharmaceuticals develop an innovative gastric acid regulator (OXM3)

FDA grants Aeglea's confirmation of the drug pegzilarginase breakthrough therapy

FDA grants fast-track eligibility for FX-322 fast-track, a research candidate drug for hearing recovery

Adelyx's key Phase 3 trial for the treatment of hyperphosphateemia reaches primary and all secondary endpoints

FDA accepts new drug applications for VX-445 (elexacaftor), tezacaftor and ivacaftor combination therapies

Incyte conducts its first patient treatment in a phase III clinical trial of ruxolitinib cream treatment

AstraZeneca announces results of Phase 3 clinical trial sedaton and aspirin combination

Twenty scientific research institutions gather edgy at The 2019 Shanghai Biofermentation Exhibition

FDA accepts biologics license application for Mercado-Ontom Ebola vaccine V920

Clinuvel's Scenese (afamelanotide) is approved for listing by FDA